Morten Hostrup

As a researcher, I am fascinated by the remarkable ability of the human body to respond and adapt to different stimuli. From the limits of human performance at one end of the spectrum to how pathophysiological conditions perturb bodily functions at the other end. In my research group, we utilize advanced clinical procedures and pharmaceutics to illuminate how the human body works - from deciphering molecular mechanisms to understanding the interplay between multi-organ systems from the lungs to the muscles.

We routinely perform human interventions in various populations, encompassing clinical trials in disease conditions, performance optimization studies in athletes, and anti-doping studies. Currently, we are exploring new-generation therapeutics with application for asthma, obesity, and muscle mass regulation. We are supported by strong networks within metabolism, protein science, and clinical research at University-affiliated hospitals around Copenhagen.

Beyond the research, I serve as Head of Studies for the Master's program in Human Physiology at University of Copenhagen and I am part of the executive board of the Clinical Academic Group (CAG) - IMPACT.

If you are interested in becoming a part of the research for a student project, please reach out. Such a project could be within:

• Mechanisms regulating muscle mass and function in response to training or pharmaceutics (e.g. anabolics)
• Clinical trials investigating the effect of new-generation compounds (e.g. monoclonal antibodies, asthma medication) or life-style interventions on clinical outcomes in disease conditions (e.g. upper and lower airway disease, cancer, and diabetes)
• Performance optimization strategies, supplements and anti-doping in athletes

Visit our research group page to find more information of our research areas and projects.

Extract of recently published research:

• Effect of lipid infusion and beta₂-adrenergic agonist, salbutamol, on insulin action in individuals with insulin resistance 
• Effect of PPARα agonist, fenofibrate, on beta cell function in newly-diagnosed type 1 diabetes 
• Muscle hypertrophic biomarkers associated with resistance training and beta₂-adrenergic agonist terbutaline 
• Performance-enhancing effects of inhaled asthma medication (beta₂-adrenergic agonists) 
• Effect of high-intensity interval training on disease control in asthma and use of inhaled glucocorticoid 

Research profile on ResearchGate and Google Scholar

Social Media profile on X

ResearcherID: D-9053-2015

Scopus Author ID: 55303297500

External activities

• Consultancy work as independent expert (e.g. anti-doping inquiries, medicine, pharma, biotech)
• Speaker/author/teacher within human physiology and medicine
• Assessor/examinator within human physiology and medicine